BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22946903)

  • 21. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
    Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
    Scott DR; Besancon M; Sachs G; Helander H
    Dig Dis Sci; 1994 Oct; 39(10):2118-26. PubMed ID: 7924730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
    Kinoshita M; Saito N; Tamaki H
    Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin.
    Sikirić P; Seiwerth S; Desković S; Grabarević Z; Marović A; Rucman R; Petek M; Konjevoda P; Jadrijević S; Sosa T; Perović D; Aralica G; Turković B
    Eur J Pharmacol; 1999 Jan; 364(1):23-31. PubMed ID: 9920181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisecretory activity of omeprazole in the conscious gastric fistula cat: comparison with famotidine.
    Coruzzi G; Bertaccini G
    Pharmacol Res; 1989; 21(5):499-506. PubMed ID: 2531863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of orally applicable new drug or drug combinations from natural origin capsaicinoids for human medical therapy.
    Mózsik G; Past T; Dömötör A; Kuzma M; Perjési P
    Curr Pharm Des; 2010; 16(10):1197-208. PubMed ID: 20166996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
    Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
    Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four response stages of capsaicin-sensitive primary afferent neurons to capsaicin and its analog: gastric acid secretion, gastric mucosal damage and protection.
    Mózsik G; Vincze A; Szolcsányi J
    J Gastroenterol Hepatol; 2001 Oct; 16(10):1093-7. PubMed ID: 11686834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
    Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cimetidine and omeprazole on aspirin- and taurocholate-induced gastric mucosal damage in the rat.
    Utley RJ; Salim AS; Carter DC
    Gut; 1985 Aug; 26(8):770-5. PubMed ID: 4018641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H; Hokari K; Asaka M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
    Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the vagus nerve in the protective action of acid inhibitors on ethanol-induced gastric mucosal damage in rats.
    Cho CH; Chen BW; Hui WM; Lam SK; Ogle CW
    J Gastroenterol Hepatol; 1992; 7(2):178-83. PubMed ID: 1571501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL; Pendleton RG; Kellner AT; Davis MA
    J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.